Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N0JE
|
||||
Former ID |
DIB004014
|
||||
Drug Name |
UP-275-22
|
||||
Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Terminated | [545814] | ||
Company |
Laboratories UPSA
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c12nc(c(c(n1ncn2)CCCC)Cc1ccc(c2c(c3nnn[nH]3)cccc2)cc1)O
|
||||
CAS Number |
CAS 186616-16-0
|
||||
Target and Pathway | |||||
Target(s) | Type-1 angiotensin II receptor | Target Info | Modulator | [543777] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Arf6 trafficking events | ||||
Arf6 signaling events | |||||
Angiopoietin receptor Tie2-mediated signaling | |||||
PathWhiz Pathway | Angiotensin Metabolism | ||||
Muscle/Heart Contraction | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.